Mineral coated microparticles delivering Interleukin-4, Interleukin-10, and Interleukin-13 reduce inflammation and improve function after spinal cord injury in a rat
Authors:
- 4 February 2025
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 386, 115179
Abstract
No abstract availableKeywords
Funding Information
- Foundation for the National Institutes of Health
This publication has 81 references indexed in Scilit:
- A Localized Materials‐Based Strategy to Non‐Virally Deliver Chondroitinase ABC mRNA Improves Hindlimb Function in a Rat Spinal Cord Injury ModelAdvanced Healthcare Materials, 2022
- Microparticles Locally Deliver Active Interleukin‐1 Receptor Antagonist In VivoAdvanced Healthcare Materials, 2018
- Nanostructured Mineral Coatings Stabilize Proteins for Therapeutic DeliveryAdvanced Materials, 2017
- IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injuryGlia, 2016
- The microanatomy of spinal cord injury: A reviewClinical Anatomy, 2014
- Multilayered Inorganic Microparticles for Tunable Dual Growth Factor DeliveryAdvanced Functional Materials, 2014
- Functionalizing Calcium Phosphate Biomaterials with Antibacterial Silver ParticlesAdvanced Materials, 2012
- Mineral Coatings for Temporally Controlled Delivery of Multiple ProteinsAdvanced Materials, 2011
- Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritisArthritis & Rheumatism, 2001
- Administration of interleukin‐10 abolishes innate resistance to Listeria monocytogenesEuropean Journal of Immunology, 1996